Mechanistic comparison of cinacalcet and oxatomide [Supplementary Concept] structure; based on molecular target overlap from BindingDB and ChEMBL binding affinity data.
20
Shared Targets
37%
Jaccard Similarity
34%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.
cinacalcet and oxatomide share 20 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.370 means 37% of the combined target set is bound by both compounds. The IDF-weighted score of 0.338 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
What do cinacalcet and oxatomide have in common?
cinacalcet and oxatomide share 20 molecular targets with a Jaccard similarity of 37%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can cinacalcet and oxatomide be combined?
cinacalcet and oxatomide share 20 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: cinacalcet or oxatomide?
In the BiohacksAI corpus: cinacalcet has 298 PubMed-indexed studies, oxatomide has 128 studies.